Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Eur J Ophthalmol ; 31(2): NP119-NP122, 2021 Mar.
Article in English | MEDLINE | ID: mdl-31390886

ABSTRACT

PURPOSE: To report three cases of juvenile myasthenia gravis aged between 18 and 24 months with ocular symptoms as their first presentation. METHOD: A case series. RESULTS: We present a case series of juvenile myasthenia gravis in a tertiary centre in Malaysia. Two of the three cases consist of a pair of twins who presented with ptosis of bilateral eyes; the first twin presented 4 months later than the second twin. These two cases were positive for anti-acetylcholine receptor antibodies and had generalized myasthenia gravis, whereas the other case was negative for receptor antibodies and was purely ocular myasthenia gravis. CONCLUSION: Juvenile myasthenia gravis is relatively rare in toddlers. Early diagnosis and commencement of treatment is important to slow the progression of the disease and avoiding life-threatening events.


Subject(s)
Blepharoptosis/diagnosis , Diseases in Twins/diagnosis , Myasthenia Gravis/diagnosis , Twins, Monozygotic , Autoantibodies/blood , Blepharoptosis/drug therapy , Blepharoptosis/genetics , Child, Preschool , Cholinesterase Inhibitors/therapeutic use , Diseases in Twins/drug therapy , Diseases in Twins/genetics , Drug Therapy, Combination , Female , Glucocorticoids/therapeutic use , Humans , Infant , Myasthenia Gravis/drug therapy , Myasthenia Gravis/genetics , Prednisolone/therapeutic use , Pyridostigmine Bromide/therapeutic use , Receptors, Cholinergic/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...